全文获取类型
收费全文 | 423223篇 |
免费 | 59333篇 |
国内免费 | 23877篇 |
专业分类
耳鼻咽喉 | 7361篇 |
儿科学 | 8012篇 |
妇产科学 | 5855篇 |
基础医学 | 37200篇 |
口腔科学 | 6074篇 |
临床医学 | 64772篇 |
内科学 | 84330篇 |
皮肤病学 | 9833篇 |
神经病学 | 29874篇 |
特种医学 | 16448篇 |
外国民族医学 | 206篇 |
外科学 | 67132篇 |
综合类 | 48786篇 |
现状与发展 | 150篇 |
一般理论 | 29篇 |
预防医学 | 24024篇 |
眼科学 | 11734篇 |
药学 | 31218篇 |
318篇 | |
中国医学 | 17345篇 |
肿瘤学 | 35732篇 |
出版年
2024年 | 418篇 |
2023年 | 8671篇 |
2022年 | 8031篇 |
2021年 | 16205篇 |
2020年 | 17345篇 |
2019年 | 12042篇 |
2018年 | 17608篇 |
2017年 | 16508篇 |
2016年 | 16968篇 |
2015年 | 21529篇 |
2014年 | 31542篇 |
2013年 | 29521篇 |
2012年 | 26168篇 |
2011年 | 29008篇 |
2010年 | 24782篇 |
2009年 | 25339篇 |
2008年 | 20409篇 |
2007年 | 18567篇 |
2006年 | 21100篇 |
2005年 | 18505篇 |
2004年 | 11832篇 |
2003年 | 10210篇 |
2002年 | 8979篇 |
2001年 | 9900篇 |
2000年 | 9763篇 |
1999年 | 10606篇 |
1998年 | 8371篇 |
1997年 | 8190篇 |
1996年 | 7038篇 |
1995年 | 6787篇 |
1994年 | 4900篇 |
1993年 | 3562篇 |
1992年 | 3661篇 |
1991年 | 3341篇 |
1990年 | 2696篇 |
1989年 | 2571篇 |
1988年 | 2219篇 |
1987年 | 1845篇 |
1986年 | 1671篇 |
1985年 | 1352篇 |
1984年 | 912篇 |
1983年 | 748篇 |
1982年 | 633篇 |
1981年 | 528篇 |
1980年 | 454篇 |
1979年 | 411篇 |
1978年 | 341篇 |
1977年 | 406篇 |
1975年 | 282篇 |
1972年 | 286篇 |
排序方式: 共有10000条查询结果,搜索用时 31 毫秒
11.
12.
Mahmut Gümüş MD Chieh-I Chen MPH Cristina Ivanescu PhD Saadettin Kilickap MD Igor Bondarenko MD Mustafa Özgüroğlu MD Miranda Gogishvili MD Haci M. Turk MD Irfan Cicin MD James Harnett PharmD Vera Mastey MS Ulrike Naumann MS Matthew Reaney MS Gerasimos Konidaris MS Medha Sasane PhD Keri J. S. Brady PhD Siyu Li PhD Giuseppe Gullo MD Petra Rietschel MD Ahmet Sezer MD 《Cancer》2023,129(1):118-129
13.
Lei Qi Mingxing Wang Yuehui Jia Yuanyuan Wang Liangfang Xue Linlin Du Shuxiu Hao Shengqi Su Ruixiang Wang Huixin Sun Chen Feng Guijin Li Qingyu Zeng Cunqi Lv Jiacheng Li Qi Li Yunyan Zhang Tong Wang 《International journal of cancer. Journal international du cancer》2023,153(6):1172-1181
Information regarding the impact of the coronavirus disease 2019 (COVID-19) pandemic on cervical cancer in mainland China is lacking. We explored its impact on the hospital attendance of patients with primary cervical cancer. We included 1918 patients with primary cervical cancer who initially attended Harbin Medical University Cancer Hospital between January 23, 2019, and January 23, 2021. Attendance decreased by 31%, from 1135 in 2019 to 783 in 2020, mainly from January to June (𝜒2 = 73.362, P < .001). The percentage of patients detected by screening decreased from 12.1% in January-June 2019 to 5.8% in January-June 2020 (𝜒2 = 7.187, P = .007). Patients with stage I accounted for 28.4% in 2020 significantly lower than 36.6% in 2019 (𝜒2 = 14.085, P < .001), and patients with stage III accounted for 27.1% in 2020 significantly higher than 20.5% in 2019 (𝜒2 = 11.145, P < .001). Waiting time for treatment was extended from 8 days (median) in January-June and July-December 2019 to 16 days in January-June (𝜒2 = 74.674, P < .001) and 12 days in July-December 2020 (𝜒2 = 37.916, P < .001). Of the 179 patients who delayed treatment, 164 (91.6%) were for the reasons of the healthcare providers. Compared to 2019, the number of patients in Harbin or non-Harbin in Heilongjiang Province and outside the province decreased, and cross-regional medical treatment has been hindered. The COVID-19 pandemic has negatively impacted cervical cancer patient attendance at the initial phase. These results are solid evidence that a strategy and mechanism for the effective attendance of cervical cancer patients in response to public health emergencies is urgently needed. 相似文献
14.
15.
16.
17.
目的 了解芦山地震5年后雅安市高血压患者心理卫生问题检出率及其影响因素,为促进地震灾区高血压患者心理健康提供参考。方法 采用分层整群随机抽样方法,于2018年12月选取雅安市高血压患者800例作为研究对象。采用自编居民基本信息调查表收集患者的基本资料,采用12项一般健康问卷(GHQ-12)评定患者近期是否存在心理卫生问题,采用Logistic回归分析其影响因素。结果 回收有效问卷744份(93.00%),检出存在心理卫生问题者79例(10.62%)。单因素分析结果显示,不同婚姻状况(P?0.01)、家庭人均月收入(P=0.012)、是否接受社会救助(χ2=25.194,P?0.01)的高血压患者心理卫生问题检出率差异均有统计学意义。Logistic回归分析显示,未婚/分居/离异/丧偶(OR=3.879,P=0.015)以及接受社会救助(OR=4.705,P?0.01)是高血压患者存在心理卫生问题的危险因素。结论 雅安市高血压患者心理卫生问题检出率较低,未婚/分居/离异/丧偶者以及接受社会救助的高血压患者心理卫生问题可能更突出。 相似文献
18.
目的 观察具有益气化痰活血作用的冠心康对人单核/巨噬细胞株THP-1细胞PERK-eIF2α信号通路及相关活化转录因子(ATF)和C/EBP同源转录因子(CHOP)的影响,探究冠心康对胆固醇在巨噬细胞内质网中的代谢稳态调节及作为“脂毒”流出后异常沉积的相关作用。方法 采用100 ng·mL-1 PMA及80 μg·mL-1氧化低密度脂蛋白诱导THP-1细胞株,构建巨噬细胞模型,并随机分为模型组、冠心康组、辛伐他汀组、正常组。分别采用10%小牛血清及含药血清干预模型细胞72 h后收集细胞。HE染色观察巨噬细胞病理形态变化,同时进行胆固醇及脂滴含量测定。分别采用Real-time PCR及Western blot法检测各组细胞PERK、eIF2α、ATF、CHOP mRNA及蛋白的表达。结果 HE染色观察到模型组细胞内呈现较多红色脂滴,经胆固醇含量测定,明显高于正常组,脂滴含量测定与前者一致(P<0.01)。模型组细胞ATF、CHOP基因表达水平均显著升高(P<0.01)。与模型组比较,冠心康组和辛伐他汀组细胞ATF、CHOP基因表达水平均显著降低(P<0.01)。PERK磷酸化以及CHOP蛋白表达水平在冠心康和辛伐他汀干预组表现为显著下调,与模型组比较,差异具有统计学意义(P<0.05)。结论 冠心康可能通过调控PERK-eIF2α-CHOP通路相关基因及蛋白,减少泡沫细胞形成,从而减轻内质网应激,维持细胞内胆固醇稳态,减少细胞内胆固醇沉积。 相似文献
19.
20.
Xi Tian Yue Wang Wenhao Xu Haidan Tang Shuxuan Zhu Aihetaimujiang Anwaier Wangrui Liu Wenfeng Wang Wenkai Zhu Jiaqi Su Yuanyuan Qu Hailiang Zhang Dingwei Ye 《International journal of cancer. Journal international du cancer》2023,152(1):66-78
In clear cell renal cell carcinoma (ccRCC), glycolysis is enhanced mainly because of the increased expression of key enzymes in glycolysis. Hence, the discovery of new molecular biomarkers for glycolysis may help guide and establish a precise system of diagnosis and treatment for ccRCC. Expression profiles of 1079 tumor samples of ccRCC patients (including 311 patients treated with everolimus or nivolumab) were downloaded from public databases. Proteomic profiles of 232 ccRCC samples were obtained from Fudan University Shanghai Cancer Center (FUSCC). Biological changes, tumor microenvironment and prognostic differences were explored between samples with various glycolysis characteristics. There were significant differences in CD8+ effector T cells, epithelial-to-mesenchymal transition and pan-fibroblast TGFb between the Low and High glyScore groups. The tumor mutation burden of the Low glyScore group was lower than that of the High glyScore group. And higher glyScore was significantly associated with worse overall survival (OS) in 768 ccRCC patients (P < .0001). External validation in FUSCC cohort also indicated that glyScore was of strong ability for predicting OS (P < .05). GlyScore may serve as a biomarker for predicting everolimus response in ccRCC patients due to its significant associations with progression-free survival (PFS). And glyScore may also predict overall survival in patients treated with nivolumab. We calculated the glyScore in ccRCC and the defined glyScore was of strong ability for predicting OS. In addition, glyScore may also serve as a biomarker for predicting PFS in patients treated with everolimus and could predict OS in patients treated with nivolumab. 相似文献